MICHAEL S ESPLIN, MD
Medical Practice in Salt Lake City, UT
License number
Utah 277127-1205
Category
Medical Practice
Type
Maternal & Fetal Medicine
Address
Address
30 E #, Salt Lake City, UT 84132
Phone
(801) 581-7092
(801) 585-5172
(801) 585-5172
Personal information
See more information about MICHAEL S ESPLIN at radaris.comName
Address
Phone
1567 Santa Clara Pkwy, Santa Clara, UT 84765
1734 N 2330 W, Saint George, UT 84770
1764 N 1450 E, Provo, UT 84604
3712 Peach St, Salt Lake Cty, UT 84109
3712 S Peach St, Salt Lake City, UT 84109
Professional information
See more information about MICHAEL S ESPLIN at trustoria.com
Dr. Michael S Esplin, Salt Lake City UT - MD (Doctor of Medicine)
Dr. Michael S Esplin, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Maternal-Fetal Medicine
Address:
Univ Of Utah OB/GYN
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
(801) 581-7647 (Phone)
Intermountain Md Ctr Mtrn/Ft Md
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
(801) 507-7400 (Phone)
Maternal Fetal Medicine
8th Ave And C St, Salt Lake City 84143
(801) 408-3446 (Phone)
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
(801) 581-7647 (Phone)
Intermountain Md Ctr Mtrn/Ft Md
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
(801) 507-7400 (Phone)
Maternal Fetal Medicine
8th Ave And C St, Salt Lake City 84143
(801) 408-3446 (Phone)
Certifications:
Fetal Medicine & Maternal Medicine, 2012, Obstetrics & Gynecology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univ Of Utah OB/GYN
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
Intermountain Md Ctr Mtrn/Ft Md
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
Maternal Fetal Medicine
8th Ave And C St, Salt Lake City 84143
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
50 N Medical Dr SUITE 2B200, Salt Lake City 84132
Intermountain Md Ctr Mtrn/Ft Md
5121 S Cottonwood St SUITE 100, Salt Lake City 84107
Maternal Fetal Medicine
8th Ave And C St, Salt Lake City 84143
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University of Utah
Graduated: 1993
University Of Ut Med Center
University of Utah
Graduated: 1993
University Of Ut Med Center
Michael Sean Esplin, Salt Lake City UT
Michael Sean Esplin, Salt Lake City UT
Specialties:
OB-GYN
Address:
50 N Medical Dr, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
Education:
Doctor of Medicine
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology, American Board of Obstetrics and Gynecology Sub-certificate in Maternal and Fetal Medicine (Obstetrics & Gynecology)
Co-Owner At Reeds Welding
Co-Owner At Reeds Welding
Location:
Greater Salt Lake City Area
Industry:
Construction
Serum Proteomics System And Associated Methods
Serum Proteomics System And Associated Methods
US Patent:
2010016, Jul 1, 2010
Filed:
Dec 26, 2007
Appl. No.:
12/521027
Inventors:
Steven William Graves - Highland UT, US
Craig Dan Thulin - Lindon UT, US
Michael Sean Esplin - Salt Lake City UT, US
Craig Dan Thulin - Lindon UT, US
Michael Sean Esplin - Salt Lake City UT, US
Assignee:
BRIGHAM YOUNG UNIVERSITY - Provo UT
International Classification:
H01J 49/26, G01N 30/00
US Classification:
250282
Abstract:
Methods for proteomic analysis are provided. For example, in one aspect a method for identifying and sequencing a peptide may include fractionating a biological sample containing a peptide of interest to at least partially isolate the peptide, obtaining mass spectra of the peptide, and accelerating the peptide into a collision chamber at a plurality of discrete collision energies for a discrete period of time to form a plurality of peptide fragments for each of the plurality of discrete collision energies. The method may further include obtaining a plurality of fragmentation mass spectra from the plurality of peptide fragments for each of the plurality of discrete collision energies, summing the plurality of fragmentation mass spectra from each of the plurality of discrete collision energies to form a plurality of discrete collision energy mass spectra, one discrete collision energy mass spectra from each discrete collision energy, summing the plurality of discrete collision energy mass spectra to form a final mass spectrum for the peptide fragments, and identifying a sequence of amino acids corresponding to the peptide from the final mass spectrum.
Identifying And Quantifying Biomarkers Associated With Preeclampsia
Identifying And Quantifying Biomarkers Associated With Preeclampsia
US Patent:
2011024, Oct 13, 2011
Filed:
Jun 24, 2009
Appl. No.:
13/000480
Inventors:
Steven W Graves - Highland UT, US
Michael Sean Esplin - Salt Lake City UT, US
Michael Sean Esplin - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
IHC HEALTH SERVICES, INC. - Salt Lake City UT
BRIGHAM YOUNG UNIVERSITY - Provo UT
IHC HEALTH SERVICES, INC. - Salt Lake City UT
BRIGHAM YOUNG UNIVERSITY - Provo UT
International Classification:
G01N 30/02, C07K 2/00
US Classification:
73 6155, 530300
Abstract:
Described herein are methods for testing pregnant subjects for preeclampsia by detecting and quantifying at least one biomarker associated with preeclampsia in a biological sample from the subject.
Identification And Quantification Of Biomarkers For Evaluating The Risk Of Preterm Birth
Identification And Quantification Of Biomarkers For Evaluating The Risk Of Preterm Birth
US Patent:
2010029, Nov 25, 2010
Filed:
Jul 17, 2008
Appl. No.:
12/669343
Inventors:
Steven William Graves - Highland UT, US
Michael Sean Esplin - Salt Lake City UT, US
Craig Dan Thulin - Lindon UT, US
Michael Sean Esplin - Salt Lake City UT, US
Craig Dan Thulin - Lindon UT, US
International Classification:
G01N 33/543, C07K 7/08, C07K 16/18, C07K 14/47
US Classification:
435 792, 530326, 5303879, 530324
Abstract:
Described herein are methods for evaluating the risk of preterm birth in pregnant subjects. The methods involve detecting and quantifying one or more biomarkers associated with preterm birth in a biological sample from the subject. Also described herein are isolated biomarkers and kits useful in predicting the risk of preterm birth.